CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 479 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $144,909 | -52.0% | 2,683 | -39.5% | 0.00% | -71.4% |
Q1 2024 | $302,085 | +41.3% | 4,432 | +29.7% | 0.01% | +133.3% |
Q4 2023 | $213,842 | +10.3% | 3,416 | -20.0% | 0.00% | -50.0% |
Q3 2023 | $193,861 | -74.8% | 4,271 | -68.8% | 0.01% | -76.9% |
Q2 2023 | $769,736 | +91317.6% | 13,711 | -26.3% | 0.03% | -3.7% |
Q1 2023 | $842 | +510.1% | 18,615 | +448.1% | 0.03% | +350.0% |
Q4 2022 | $138 | -100.0% | 3,396 | -87.4% | 0.01% | -79.3% |
Q3 2022 | $1,763,000 | +62.5% | 26,990 | +51.1% | 0.03% | +20.8% |
Q2 2022 | $1,085,000 | +162.7% | 17,862 | +171.9% | 0.02% | +500.0% |
Q1 2022 | $413,000 | +76.5% | 6,570 | +113.0% | 0.00% | 0.0% |
Q4 2021 | $234,000 | -28.2% | 3,085 | +5.9% | 0.00% | -50.0% |
Q3 2021 | $326,000 | -83.3% | 2,912 | -75.9% | 0.01% | -84.3% |
Q2 2021 | $1,953,000 | -64.8% | 12,061 | -73.5% | 0.05% | -45.2% |
Q1 2021 | $5,552,000 | +997.2% | 45,570 | +1278.8% | 0.09% | +520.0% |
Q4 2020 | $506,000 | +932.7% | 3,305 | +462.1% | 0.02% | +1400.0% |
Q3 2020 | $49,000 | +172.2% | 588 | +142.0% | 0.00% | 0.0% |
Q2 2020 | $18,000 | -71.0% | 243 | -76.1% | 0.00% | -80.0% |
Q4 2019 | $62,000 | +3000.0% | 1,016 | +2061.7% | 0.01% | – |
Q3 2019 | $2,000 | -85.7% | 47 | -83.7% | 0.00% | -100.0% |
Q2 2019 | $14,000 | -65.9% | 288 | -74.9% | 0.00% | -50.0% |
Q1 2019 | $41,000 | -95.6% | 1,148 | -96.5% | 0.00% | -97.0% |
Q4 2018 | $929,000 | +1329.2% | 32,502 | +2103.5% | 0.07% | +1240.0% |
Q3 2018 | $65,000 | +71.1% | 1,475 | +125.9% | 0.01% | +150.0% |
Q2 2018 | $38,000 | -67.2% | 653 | -74.2% | 0.00% | -80.0% |
Q1 2018 | $116,000 | +364.0% | 2,532 | +82.6% | 0.01% | +400.0% |
Q3 2017 | $25,000 | +150.0% | 1,387 | +189.6% | 0.00% | +100.0% |
Q4 2016 | $10,000 | – | 479 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |